🇺🇸 FDA
Patent

US 8329753

Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition

granted A61KA61K31/325A61P

Quick answer

US patent 8329753 (Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition) held by The Regents of the University of Colorado expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/325, A61P, A61P29/00, A61P35/00